Table 1

Antagonism of agonist-mediated M1 mAChR activation of nNOS

AgonistAntagonistpKB1-as1-bdf1-c
CChAtropine8.69  ± 0.140.99  ± 0.2532
Xanomeline8.32  ± 0.160.84  ± 0.2822
CChPirenzepine7.74  ± 0.081.10  ± 0.1113
Xanomeline7.92  ± 0.671-d 1.10  ± 0.6213

Enzyme activity was assayed by measuring the conversion ofl-[3H]arginine tol-[3H]citrulline in response to agonist for 1 h at 37°C in a HEPES-based buffer, as described in the text and shown in Figs. 4 and 6. Parameters (±S.E.M.) were derived from computer-assisted nonlinear regression analysis, according to eq. 2 in the text.

  • 1-a Negative logarithm of the antagonist dissociation equilibrium constant, estimated with the slope parameter constrained to unity.

  • 1-b Equivalent to the Schild slope parameter. None of these values were significantly different (p > .05) from 1.

  • 1-c Degrees of freedom.

  • 1-d pA2 value only; agonist concentration-response curves did not conform to simple competition in the presence of the antagonist.